tiprankstipranks
Advertisement
Advertisement

BBIO Stock Latest News

Zemansky Reiterates Buy on BridgeBio, Nudges Price Target to $96 on Attruby Edge and Reduced Tafamidis Patent Overhang
RatingsZemansky Reiterates Buy on BridgeBio, Nudges Price Target to $96 on Attruby Edge and Reduced Tafamidis Patent Overhang
1h ago
BBIO
BofA ups BridgeBio price target, cites exclusivity ‘disappointment’ for pullback
PremiumThe Fly
BofA ups BridgeBio price target, cites exclusivity ‘disappointment’ for pullback
18h ago
PFE
BBIO
Midday Fly By: OpenAI said to miss targets, Coca-Cola reports Q1 beat
PremiumThe Fly
Midday Fly By: OpenAI said to miss targets, Coca-Cola reports Q1 beat
20h ago
GM
KO
Pfizer Vyndamax settlement at lower end of expectations, says Morgan Stanley
PremiumThe Fly
Pfizer Vyndamax settlement at lower end of expectations, says Morgan Stanley
21h ago
PFE
BBIO
BridgeBio turns negative after Pfizer details tamidis settlement
PremiumThe Fly
BridgeBio turns negative after Pfizer details tamidis settlement
21h ago
PFE
BBIO
BridgeBio jumps 12% to $83.18 as Pfizer confirms tafamidis settlement
PremiumThe FlyBridgeBio jumps 12% to $83.18 as Pfizer confirms tafamidis settlement
21h ago
PFE
BBIO
Pfizer announces three settlement agreements for Vyndamax
Premium
The Fly
Pfizer announces three settlement agreements for Vyndamax
21h ago
PFE
BBIO
BridgeBio could trade to $90-$110 on Pfizer settlement, says Mizuho
Premium
The Fly
BridgeBio could trade to $90-$110 on Pfizer settlement, says Mizuho
21h ago
PFE
BBIO
Apparent Hikma settlement ‘key positive’ for BridgeBio, says Barclays
PremiumThe Fly
Apparent Hikma settlement ‘key positive’ for BridgeBio, says Barclays
22h ago
PFE
BBIO
3 Best Stocks to Buy This Week, According to Analysts – April 26-May 1
PremiumMarket News
3 Best Stocks to Buy This Week, According to Analysts – April 26-May 1
2d ago
ZS
BBIO
BridgeBio Buy Rating Reiterated as Analyst Sees Extended Patent Runway, Delayed Tafamidis Competition and Maintains $100 Price Target
PremiumRatings
BridgeBio Buy Rating Reiterated as Analyst Sees Extended Patent Runway, Delayed Tafamidis Competition and Maintains $100 Price Target
2d ago
BBIO
Texas Instruments upgraded, Circle downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Texas Instruments upgraded, Circle downgraded: Wall Street’s top analyst calls
20d ago
KR
ZS
BridgeBio initiated with an Outperform at RBC Capital
PremiumThe FlyBridgeBio initiated with an Outperform at RBC Capital
21d ago
BBIO
BridgeBio: Advancing First-in-Class LGMD Therapy and Blockbuster ATTR Franchise Underpin Reiterated Buy and $100 Target
Premium
Ratings
BridgeBio: Advancing First-in-Class LGMD Therapy and Blockbuster ATTR Franchise Underpin Reiterated Buy and $100 Target
29d ago
BBIO
BridgeBio Files NDA for LGMD2I/R9 Oral Therapy
Premium
Company Announcements
BridgeBio Files NDA for LGMD2I/R9 Oral Therapy
29d ago
8K
BBIO
BridgeBio presents long-term efficacy, safety data from ATTRibute-CM trial
PremiumThe Fly
BridgeBio presents long-term efficacy, safety data from ATTRibute-CM trial
30d ago
BBIO
BridgeBio submits BBP-418 NDA to FDA
PremiumThe Fly
BridgeBio submits BBP-418 NDA to FDA
30d ago
BBIO
BridgeBio price target raised to $106 from $91 at Mizuho
PremiumThe Fly
BridgeBio price target raised to $106 from $91 at Mizuho
1M ago
BBIO
Buy Rating on BridgeBio: Differentiated Rare-Disease Portfolio and Clear Path to Profitability Support Robust Long-Term Growth
PremiumRatings
Buy Rating on BridgeBio: Differentiated Rare-Disease Portfolio and Clear Path to Profitability Support Robust Long-Term Growth
1M ago
BBIO
BridgeBio presents Phase 3 FORTIFY interim analysis results
PremiumThe FlyBridgeBio presents Phase 3 FORTIFY interim analysis results
2M ago
BBIO
Qualcomm downgraded, Rivian upgraded: Wall Street’s top analyst calls
Premium
The Fly
Qualcomm downgraded, Rivian upgraded: Wall Street’s top analyst calls
2M ago
LTH
NVO
BridgeBio initiated with an Outperform at William Blair
Premium
The Fly
BridgeBio initiated with an Outperform at William Blair
2M ago
BBIO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >